JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

《心血管药理学和治疗学杂志》是一本同行评审的杂志，出版了原始的人类基础研究、原始动物研究和原始的实验研究，具有潜在的临床应用于心血管药理学和治疗学。实验研究的重点是翻译研究。该杂志还发表关于基础研究、临床研究、社论、评论、观点和争议的评论文章。选定的期刊补充也将出版。未来的重点将包括心脏保护疗法、干细胞疗法、再生心脏学、预防心脏病疗法（风险因素管理）和抗心律失常疗法。选定的期刊补充也将出版。《心血管药理学与治疗学杂志》（JCPT）的每一期内容丰富的期刊都为心脏病学家、临床药理学家和研究人员提供了与疾病相关的新心血管药物的临床和实验研究以及其他治疗选择。JCPT每年检查和分析四次，包括：减少心肌梗死面积的药物减少心肌重塑的药物血管紧张素转换酶抑制剂抗高血压治疗心律不整心房颤动β受体阻滞剂疗法心源性中风心肌病心脏保护剂心肺复苏术心血管综合治疗慢性咽峡炎慢性心脏缺血充血性心力衰竭冠状动脉疾病冠状动脉血运重建肝素治疗高血压病低血压移植设备缺血性心脏病心肌梗塞经皮冠状动脉介入治疗外周动脉疾病预处理/后处理再生心脏病学干细胞治疗

Journal of Cardiovascular Pharmacology and Therapeutics is a peer-reviewed journal that publishes original basic human studies, original animal studies, and original bench research with potential clinical application to cardiovascular pharmacology and therapeutics. The focus of the experimental studies is translational research. The journal also publishes review articles on basic research, clinical research, editorials, commentaries, points of view, and controversies. Selected journal supplements will also be published. Future focus will include cardioprotective therapies, stem cell therapy, regenerative cardiology, therapies for preventive cardiology (risk factor management), and antiarrhythmic therapies. Selected journal supplements will also be published.Every informative issue of Journal of Cardiovascular Pharmacology and Therapeutics (JCPT) offers cardiologists, clinical pharmacologists and researchers involved in disease relevant clinical and experimental investigations of newer cardiovascular drugs and other therapeutic options. Four times a year, JCPT examines and analyzes arenas such as:Agents that Reduce Myocardial Infarct SizeAgents that Reduce Myocardial RemodelingAngiotensin Converting Enzyme InhibitorsAntihypertensive TherapyArrhythmiasAtrial FibrillationBeta-Blocker TherapiesCardioembolic StrokeCardiomyopathyCardioprotective AgentsCardiopulmonary ResuscitationCardiovascular Combination TherapiesChronic AnginaChronic Cardiac IschemiaCongestive Heart FailureCoronary Artery DiseaseCoronary RevascularizationHeparin TherapiesHypertensionHypotensionImplantable DevicesIschemic Heart DiseaseMyocardial InfarctionPercutaneous Coronary InterventionsPeripheral Arterial DiseasePreconditioning/PostconditioningRegenerative CardiologyStem Cell Therapy